(Q34738217)

4 August 2017

title

Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem (English)

1 reference

4 August 2017

1 reference

Eyles DW

1

1 reference

4 August 2017

Avent KM

series ordinal

2

1 reference

4 August 2017

Stedman TJ

series ordinal

3

1 reference

4 August 2017

Pond SM

series ordinal

4

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

4 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

4 August 2017

volume

60

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

529-534

1 reference

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Metabolic studies on haloperidol and its tetrahydropyridine analog in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Formation of pyridinium species of haloperidol in human liver and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900656-X

10.1016/S0024-3205(96)00656-X

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference